Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve …

I Kovanecz, S Rivera, G Nolazco… - The journal of sexual …, 2012 - academic.oup.com
Introduction Long-term daily administration of phosphodiesterase type 5 (PDE5) inhibitors in
the rat prevents or reverses corporal veno-occlusive dysfunction (CVOD) and smooth …

The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate

JP Mulhall, A Müller, JF Donohue… - The journal of sexual …, 2008 - academic.oup.com
Introduction Radical prostatectomy (RP) is associated with erectile dysfunction (ED). A
single, placebo-controlled, human study has assessed the effects of regular sildenafil use …

Dual strategy with oral phosphodiesterase type 5 inhibition and intracavernosal implantation of mesenchymal stem cells is superior to individual approaches in the …

JI Martínez-Salamanca, M Zurita… - The Journal of …, 2016 - academic.oup.com
Introduction Novel effective therapeutic strategies are necessary for treating erectile
dysfunction secondary to cavernous nerve injury (CNI). Aim To functionally evaluate the …

Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats

I Kovanecz, A Rambhatla, M Ferrini, D Vernet… - International journal of …, 2008 - nature.com
It was recently reported in the rat that vardenafil given in a continuous long-term manner was
successful in preventing smooth muscle fibrosis in the penile corpora cavernosa and …

Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after …

F Sirad, S Hlaing, I Kovanecz, JN Artaza… - The journal of sexual …, 2011 - academic.oup.com
Introduction It has been shown that phosphodiesterase type 5 (PDE5) inhibitors preserve
smooth muscle (SM) content and ameliorate the fibrotic degeneration normally seen in the …

Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat

MG Ferrini, I Kovanecz, S Sanchez… - Biology of …, 2007 - academic.oup.com
Aging-related erectile dysfunction is characterized by a loss of smooth muscle cells (SMCs)
and fibrosis in the corpora cavernosa, and functionally by corporal veno-occlusive …

Combined therapeutic effect of udenafil and adipose-derived stem cell (ADSC)/brain-derived neurotrophic factor (BDNF)–membrane system in a rat model of …

HH Jeong, S Piao, JN Ha, IG Kim, SH Oh, JH Lee… - Urology, 2013 - Elsevier
OBJECTIVE: To prevent cavernous nerve injury and corpus cavernosum apoptosis-induced
erectile dysfunction (ED) after prostatectomy surgery, we investigated whether oral …

A mouse model of cavernous nerve injury-induced erectile dysfunction: functional and morphological characterization of the corpus cavernosum

HR Jin, YG Chung, WJ Kim, LW Zhang… - The Journal of …, 2010 - academic.oup.com
Introduction With the advent of genetically engineered mice, it seems important to develop a
mouse model of cavernous nerve injury (CNI). Aim To establish a mouse model of CNI …

Udenafil enhances the recovery of erectile function and ameliorates the pathophysiological consequences of cavernous nerve resection

CH Lee, JH Shin, GJ Ahn, KK Kang… - The Journal of Sexual …, 2010 - academic.oup.com
Introduction Radical prostatectomy is the treatment of choice for prostate cancer patients.
Despite the introduction of nerve-sparing surgical techniques, its success is not entirely …

Intravenous preload of mesenchymal stem cells rescues erectile function in a rat model of cavernous nerve injury

A Takayanagi, M Sasaki… - The journal of sexual …, 2015 - academic.oup.com
Introduction We evaluated the potential preventive effects and mechanisms of intravenously
preloaded mesenchymal stem cells (MSCs) for erectile dysfunction (ED) in a cavernous …